GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Igi, Inc. (IG) [hlAlert]

Rating:
Outperform
IG
up 12.66 %

Igi, Inc. (IG) rated Outperform with price target $8 by Oppenheimer

Posted on: Thursday,  Aug 28, 2014  8:25 AM ET by Oppenheimer

Oppenheimer rated Outperform Igi, Inc. (AMEX: IG) on 08/28/2014, when the stock price was $6.79. Since
then, Igi, Inc. has gained 12.67% as of 08/27/2015's recent price of $7.65.
If you would have followed this Oppenheimer's recommendation on IG, you would have gained 12.66% of your investment in 364 days.

IGI Inc. is a company committed to growth by applying proprietary technologies to achieve cost-effective solutions for varied customer needs. IGI offers the patented Novasome lipid vesicle encapsulation technology which contributes value-added qualities to cosmetics, skin care products, dermatological formulations and other consumer products, providing improved dermal absorption, low potential for irritations, controlled and sustained release as well as improved stability. IGI has licensed Novasome lipid vesicle encapsulation technology to leading global dermatological and skin care companies including Johnson & Johnson Consumer Products, Inc., Estee Lauder Companies, Chattem Inc., Genesis Pharmaceutical, Inc., Apollo Pharmaceutical, Inc. and Vetoquinol USA. IGI sub-licensed the rights to obtain FDA approval for and market IGI's PTH compound using Novasome lipid vesicle encapsulation technology for psoriasis, which is being reformulated for Phase II clinical trials, to Manhattan Pharmaceuticals, Inc.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/28/2014 8:25 AM Buy
None
6.79 8.00
as of 10/17/2014
1 Week up  5.21 %
1 Month up  15.34 %
3 Months up  30.63 %
1 YTD up  30.63 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy